What You Should Know: -Tempus, an $8B precision medicine company, is providing genomic sequencing for 300 eligible pediatric cancer patients annually through their new collaboration with the Children’s Oncology Group (COG). Tempus’ support for COG – a leader in pediatric oncology research – will assist with matching patients to clinical trials like the Pediatric MATCH Screening Trial APEC1621SC (NCT03155620), which is studying the effectiveness of genetic testing-directed treatment in
Read More
Pediatric Precision Medicine
Buoy Health Integrates with Boston Children’s to Improve Pediatric Capabilities
Buoy Health, an AI-focused health technology startup that develops digital tools to help people from the moment they get sick start their care on the right foot, today named Boston Children’s Hospital its first innovation partner. As part of the multi-pronged partnership, Boston Children’s Hospital will integrate Buoy’s advanced AI into its website to help parents around the globe identify the right course of treatment the moment their children’s symptoms hit.Innovation Partnership DetailsAs
Read More
NIH Awards UCSF Researchers $11.7M Grant to Launch Pediatric Precision Medicine Equity Program
The National Institutes of Health (NIH) has awarded a team of UC San Francisco researchers with a four-year $11.7 million grant to launch a new Prenatal and Pediatric Genomic Sequencing (P3EGS ) program at UCSF, according to UCSF news. Over the four-year span, the program is focused on pursuing equity in the implementation of genomic precision medicine for children and families in the San Francisco Bay Area.As part of the pediatric precision medicine program, the P3EGS team will recruit 1,100
Read More
